Fort Washington Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-712
| Closed | -$246K | – | 560 |
|
|
2018
Q2 | $246K | Sell |
712
-2,721
| -79% | -$940K | ﹤0.01% | 509 |
|
|
2018
Q1 | $1.18M | Sell |
3,433
-445
| -11% | -$153K | 0.01% | 352 |
|
|
2017
Q4 | $1.46M | Buy |
3,878
+35
| +0.9% | +$13.2K | 0.01% | 363 |
|
|
2017
Q3 | $1.72M | Sell |
3,843
-145
| -4% | -$64.8K | 0.03% | 246 |
|
|
2017
Q2 | $1.96M | Sell |
3,988
-20
| -0.5% | -$9.82K | 0.03% | 226 |
|
|
2017
Q1 | $1.55M | Sell |
4,008
-285
| -7% | -$110K | 0.02% | 262 |
|
|
2016
Q4 | $1.58M | Sell |
4,293
-305
| -7% | -$112K | 0.03% | 262 |
|
|
2016
Q3 | $1.85M | Sell |
4,598
-20
| -0.4% | -$8.04K | 0.03% | 210 |
|
|
2016
Q2 | $1.61M | Sell |
4,618
-1,297
| -22% | -$453K | 0.03% | 229 |
|
|
2016
Q1 | $2.13M | Buy |
+5,915
| New | +$2.13M | 0.04% | 201 |
|
|
2015
Q4 | – | Sell |
-7,335
| Closed | -$3.41M | – | 426 |
|
|
2015
Q3 | $3.41M | Sell |
7,335
-275
| -4% | -$128K | 0.07% | 162 |
|
|
2015
Q2 | $3.88M | Buy |
7,610
+700
| +10% | +$357K | 0.07% | 150 |
|
|
2015
Q1 | $3.12M | Sell |
6,910
-250
| -3% | -$113K | 0.06% | 167 |
|
|
2014
Q4 | $2.94M | Sell |
7,160
-50
| -0.7% | -$20.5K | 0.06% | 172 |
|
|
2014
Q3 | $2.6M | Sell |
7,210
-230
| -3% | -$82.9K | 0.05% | 190 |
|
|
2014
Q2 | $2.1M | Sell |
7,440
-1,125
| -13% | -$318K | 0.04% | 226 |
|
|
2014
Q1 | $2.57M | Sell |
8,565
-1,300
| -13% | -$390K | 0.06% | 185 |
|
|
2013
Q4 | $2.72M | Buy |
9,865
+2,025
| +26% | +$557K | 0.06% | 215 |
|
|
2013
Q3 | $2.45M | Buy |
7,840
+5,740
| +273% | +$1.8M | 0.06% | 242 |
|
|
2013
Q2 | $472K | Buy |
+2,100
| New | +$472K | 0.01% | 355 |
|